Journal article
The prognostic significance of smoking cessation after acute coronary syndromes: An observational, multicentre study from the Melbourne interventional group registry
MB Yudi, O Farouque, N Andrianopoulos, AE Ajani, K Kalten, AL Brennan, J Lefkovits, C Hiew, E Oqueli, CM Reid, SJ Duffy, DJ Clark
BMJ Open | BMJ PUBLISHING GROUP | Published : 2017
Abstract
Objective We aim to ascertain the prognostic significance of persistent smoking and smoking cessation after an acute coronary syndrome (ACS) in the era of percutaneous coronary intervention (PCI) and optimal secondary prevention pharmacotherapy. Methods Consecutive patients from the Melbourne Interventional Group registry (2005-2013) who were alive at 30 days post-ACS presentation were included in our observational cohort study. Patients were divided into four categories based on their smoking status: non-smoker; ex-smoker (quit >1 month before ACS); recent quitter (smoker at presentation but quit by 30 days) and persistent smoker (smoker at presentation and at 30 days). The primary endpoint..
View full abstractGrants
Awarded by National Health and Medical Research Council
Funding Acknowledgements
The Melbourne Interventional Group acknowledge sunrestricted educational grant funding from: Abbott Vascular, Astra-Zeneca, Medtronic, MSD, Pfizer, Servier and The Medicines Company. These companies do not have access to the data and do not have the right to review manuscripts before publication. Professor SJD & Professor Reid's work is funded by National Health and Medical Research Council of Australia Grants.